Optogenetics refers to the use of genetic engineering or gene therapy to introduce light sensitive molecules (opsins) into nerves to make them responsive to low-power light. Light can provide highly focussed stimuli and is not limited by conductive spread in the same way as electrical current.

Our research is exploring the potential of optical stimulation to advance precision in neural stimulation and expand the range of health conditions that can be treated via bionic devices.

Further information

Click here to download our factsheet or please view the animation below. 

Research team

Program leader: A/Prof Rachael Richardson

Team membersA/Prof Andrew WiseA/Prof James Fallon, Dr Alex Thompson

Collaborators: Prof Stephen O’Leary (University of Melbourne) and Prof Paul Stoddart (Swinburne University).

Animation: Improving cochlear implant performance with optical stimulation